Lipidomics Reveals Circulating Lipid Biomarkers for Retinopathy of Prematurity in Preterm Infants

Kajetan Trošt1, Qian Gao1, Jasmin Pernille Hjerresen1

  • 1Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.

Ophthalmology Science
|April 20, 2026
PubMed

Insights

Lipid profiles in preterm infants change significantly during the neonatal period. Altered lipid metabolism, particularly involving phosphatidylcholines, is associated with retinopathy of prematurity (ROP) severity.

Area of Science:

  • Neonatal Medicine
  • Ophthalmology
  • Metabolomics

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of blindness in preterm infants.
  • While high oxygen is a known factor, metabolic influences like lipids are increasingly implicated in ROP pathophysiology.

Purpose of the Study:

  • To explore the association between lipid profiles and ROP development in preterm infants.
  • To investigate how lipid species change during the neonatal period in relation to ROP severity.

Main Methods:

  • An exploratory study involving 110 preterm infants (born before 32 weeks gestation).
  • ROP screening and bi-weekly blood sample collection.
  • Lipidomics analysis of 485 lipid species and statistical modeling.

Main Results:

  • All major lipid classes (310 species) showed significant changes during the neonatal period.
  • Early lipid profiles, especially phosphatidylcholines, correlated with ROP severity.
  • Glycerophospholipids and sphingolipids changed slower in infants with severe ROP (stage 2-3).

Conclusions:

  • Significant changes in lipid profiles occur in preterm infants throughout the neonatal period.
  • Lipid metabolism alterations are associated with ROP pathogenesis.
  • Further research into dyslipidemia in ROP is warranted.
Abstract